RxDoctor Payments Data

Robert Ezewuiro

Primary Podiatric Medicine · Lancaster, SCNPI 1134571334

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (37.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Peerless Surgical Inc. at 36.9% of the total. Reporting peaked in 2021 at $5,181 and has fallen 83.3% since, to $865 in 2025.

$20,624in general payments, 2019–2025

Across 242 payments — averaging $85.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Peerless Surgical Inc.$8K
  • Arthrex$4K
  • Triad Life Sciences Inc.$2K
  • Stryker$1K
  • Treace Medical Concepts, Inc.$1K
  • Convatec Inc.$1K
  • plus $4K from 30 others

What the payments were for

  • Travel & lodging$5,40826%
  • Food & beverage$7,41636%
  • Education$7,80038%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few primary podiatric medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$227,384
Medicare patients
443
Services billed
1,842

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Linezolid14$1,118
Terbinafine Hcl16$289
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav36$250
Colchicine15$188
Gabapentin17$144
Mupirocin14$137
Methylprednisolone18$106
Allopurinol18$85
Cefadroxil16$78
Doxycycline Hyclate11$66
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$63
Triamcinolone Acetonide11$61

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Lancaster

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →